CryoLife, Inc. (CRY) Tops Q2 EPS by 6c; Guides FY11 EPS, Revs
Tweet
Share
E-mailGet Alerts CRY Hot Sheet
Price: $17.60 +0.28%
Financial Fact:
Other (income) expense, net: 21K
Today's EPS Names:
OFLX, VAXX, NMRD, More
Financial Fact:
Other (income) expense, net: 21K
Today's EPS Names:
OFLX, VAXX, NMRD, More
Join SI Premium – FREE
CryoLife, Inc. (NYSE: CRY) reported Q2 EPS of $0.12, $0.06 better than the analyst estimate of $0.06. Revenue for the quarter came in at $29.4 million versus the consensus estimate of $30.37 million.
Sees FY2011 adjusted EPS of $0.28-$0.32, versus the consensus of $0.28. Also sees FY2011 revenue of $122-$125 million, versus the consensus of $124.76 million.
Sees FY2011 adjusted EPS of $0.28-$0.32, versus the consensus of $0.28. Also sees FY2011 revenue of $122-$125 million, versus the consensus of $124.76 million.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Ondas Holdings Inc. (ONDS) Misses Q2 EPS by 9c
- Beyond Air, Inc. (XAIR) Tops Q1 reported Q1 Revenue ; Offers Guidance
- Bit Digital (BTBT) Misses Q2 EPS by 27c
Create E-mail Alert Related Categories
Earnings, GuidanceSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
